Efficacy to observe duodenal diseases using Endo-Cytoscopy-System in vivo

Efficacy to observe duodenal diseases using Endo-Cytoscopy-System in vivo - Efficacy to observe duodenal diseases using Endo-Cytoscopy-System in vivo

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013431

Enrollment

Registered

2014-03-17

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

duodenal adenoma,early duodenal carcinoma,malignant lymphoma of the duodenum

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over 20 years old person who will undergo treatment for duodenal adenoma, early duodenal carcinoma and malignant lymphoma of the duodenum.

Exclusion criteria

Exclusion criteria: 1.The patients with severe complication 2.The patients who the physitian judged as inappropriate

Design outcomes

Primary

Measure	Time frame
The sensitivity	—

Secondary

Measure	Time frame
The specificity	—

Countries

Japan

Contacts

Public ContactMasakazu Kikuchi

Nagoya University Graduate School Department of Gastroenterology

mkikuchi@med.nagoya-u.ac.jp052-744-2784

Outcome results